Skip to main content
Journal cover image

Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C

Publication ,  Conference
Clark, PJ; Santoro, R; Piazzolla, V; Mottola, L; Bacca, D; Dello Iacono, N; Grimaldi, S; Quarta, A; Urban, TJ; Naggie, S; Patel, K; Muir, AJ ...
Published in: HEPATOLOGY
October 1, 2012

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2012

Volume

56

Start / End Page

1028A / 1029A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clark, P. J., Santoro, R., Piazzolla, V., Mottola, L., Bacca, D., Dello Iacono, N., … Mangia, A. (2012). Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C. In HEPATOLOGY (Vol. 56, pp. 1028A-1029A). Boston, MA: WILEY-BLACKWELL.
Clark, Paul J., Rosanna Santoro, Valeria Piazzolla, Leonardo Mottola, D. Bacca, N. Dello Iacono, Salvatore Grimaldi, et al. “Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C.” In HEPATOLOGY, 56:1028A-1029A. WILEY-BLACKWELL, 2012.
Clark PJ, Santoro R, Piazzolla V, Mottola L, Bacca D, Dello Iacono N, et al. Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C. In: HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 1028A-1029A.
Clark, Paul J., et al. “Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C.” HEPATOLOGY, vol. 56, WILEY-BLACKWELL, 2012, pp. 1028A-1029A.
Clark PJ, Santoro R, Piazzolla V, Mottola L, Bacca D, Dello Iacono N, Grimaldi S, Quarta A, Urban TJ, Naggie S, Patel K, Thompson AJ, Muir AJ, Mangia A. Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C. HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 1028A-1029A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2012

Volume

56

Start / End Page

1028A / 1029A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics